. Apparent kinetic parameters of Psp2,6ST(15-501)-His 6 and His 6 -Pd2,6ST(16-497)…….....S2 Figure S1 . SDS-PAGE of A, Psp2,6ST(15-501)-His 6 and B, MBP-Psp2,6ST(15-501)-His 6 . Lanes: 1, whole cell extraction before induction; 2, whole cell extraction after induction; 3, cell lysate after induction; 4, Ni 2+ -column purified protein; 5, protein standards. 2+ and Mn  2+ ) , EDTA, and DTT on the sialyltransferase activity of Psp2,6ST(15-501)-His 6 by quantitative HPLC analysis. White columns, CMP-Neu5Ac and LacMU were used as substrates; black columns, CMP-Neu5Ac and GalNAc2AA were used as substrates. Reaction conditions were the same as those for pH profiles.
Figure S2. Effects of metal ions (Mg
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A. B. Figure S3 . The pH profiles of A, Psp2,6ST(15-501)-His 6 and B, His 6 -Pd2,6ST(16-497) when LacMU (■), GalNAc2AA (▲), or GalNAcSer () was used as the sialyltransferase acceptor. 100% conversion was defined as the formation of 1 mM product (Neu5Ac2-6LacMU or Neu5Ac2-6GalNAc2AA or Neu5Ac2-6GalNAcSer -NTA agarose (nickel-nitrilotriacetic acid agarose) was from 5 PRIME (Gaithersburg, MD).
S3
Cloning, expression, and purification of Psp2,6ST(15-501)-His 6 Psp2,6ST was cloned into pET22b(+) and pMal-c4x vectors and expressed in E. coli BL21 (DE3) cells as C-His 6 -tagged fusion proteins with or without additional N-MBP-tag. The primers used to clone Psp2,6ST(15-501)-His 6 in pET22b(+) vector were: forward primer 5'-GATCCATATGTGTAATAATAGCGAAGAAAATAC-3' (NdeI restriction site is underlined), reverse primer 5'-CCGCTCGAGTGCCCAAAACAGGACGTTTT-3' (XhoI restriction site is underlined). The primers used to clone MBP-Psp2,6ST(15-501)-His 6 fusion protein were: forward primer is same as the one used in cloning Psp2,6ST(15-501)-His 6 fusion protein, reverse primer 5'-ACGCGTCGACTTAGTGGTGGTGGTGGTGGTGTGCCCAA-3' (SalI restriction site is underlined, codons encoding hexa-histidine are in italics). PCRs for amplifying the target gene were performed in a 50 L reaction mixture containing template DNA (1 g), forward and reverse primers (1 M each), 10 × Herculase buffer (5 L), dNTP mixture (1 mM), and 5 U (1 L) of Herculase-enhanced DNA polymerase. The reaction mixture was subjected to 29 cycles of amplification with an annealing S4 temperature of 52 C. The resulting PCR product was purified and digested with restriction enzymes. The purified and digested PCR product was ligated with predigested vectors and transformed into E. coli DH5 electrocompetent cells. Selected clones were grown for minipreps and characterization by restriction mapping and DNA sequencing performed by Davis Sequencing Facility in the University of California-Davis.
Positive plasmid was selected and transformed into BL21 (DE3) chemically competent cells. The plasmid-bearing E. coli strain was cultured in LB-rich medium (10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl) supplemented with ampicillin (100 g/mL). Overexpression of the target protein was achieved by inducing the E. coli culture with 0.3 mM of isopropyl-1-thio--D-galactopyranoside (IPTG) when the OD 600nm of the culture reaches 0.8-1.0 and incubating at 20 C for 20 h with vigorous shaking at 250 rpm in a C25KC incubator shaker (New Brunswick Scientific, Edison, NJ).
Target proteins were purified from cell lysate. To obtain the cell lysate, cell pellet harvested by centrifugation at 4000 rpm for 2 h was resuspended in lysis buffer (pH 7.5, 100 mM Tris-HCl containing 0.1% Triton X-100) (20 mL/L cell culture). Lysozyme (50 g/mL) and DNaseI (3 g/mL) were then added and the mixture was incubated at 37 C for 1 hour with vigorous shaking. Cell lysate was obtained by centrifugation at 11,000 rpm for 30 min as the supernatant. Purification of His-tagged proteins from the lysate was achieved using an AKTA FPLC system (GE Healthcare) equipped with a HisTrapTM FF 5 mL column. The column was pre-equilibrated with 10 column volumes of binding buffer (5 mM imidazole, 0.5M NaCl, 50 mM Tris-HCl, pH 7.5) before the lysate was loaded. Followed by washing with eight column volumes of binding buffer, 10 column volumes of washing buffer (50 mM imidazole, 0.5 M NaCl, 50 mM Tris-HCl, pH 7.5), the protein was eluted with a linear gradient of elute buffer containing 50-250 mM imidazole in Tris-HCl buffer (50 mM, pH 7.5, 0.5 M NaCl). The fractions containing the purified enzymes were collected and stored at 4 C.
Protein concentration was determined in a 96-well plate using bicinchoninic acid with BSA as standard. The absorbance was measured at 562 nm using a plate reader.
SDS-PAGE analysis of Psp2,6ST(15-501)-His 6
SDS-PAGE analysis ( Figure S1 , A) shows both the recombinant proteins in pET system and pMal-c4x system can be well expressed with molecular weight of about 56 kDa and 99.5 kDa respectively, which are close to 55 kDa calculated for the Psp2,6ST(15-501)-His 6 and 98 kDa calculate for the MBPPsp2,6ST(15-501)-His 6 . The SDS-PAGE analysis of Psp26ST(15-501)-His 6 in pET22b (+) system (Figure S1A) indicates that it can be expressed in a large amount which consists of about 80% of the total protein extracts from E. coli host cells. But the soluble portion of the target protein that can be observed in the lysate is not high. So pMal-c4x expression system was tested to improve the protein solubility. However, SDS-PAGE analysis of MBP-Psp2,6ST(15-501)-His 6 expression ( Figure S1B ) showed that the pMal-c4x expression system did not improve the expression level. up to 50 mM does not affect the sialyltransferase activity of the enzyme, but the activity drops a little when Mn 2+ ion is used in the reaction system. DTT up to 10 mM does not significantly increase the activity of the enzyme for both acceptor LacMU and GalNAc2AA, indicating disulfide formation is not required for the sialyltransferase activity of Psp2,6ST(15-501)-His 6 .
Effects of metal ions, DTT and EDTA
pH profile study for Psp2,6ST(15-501)-His 6 and His 6 -Pd2,6ST(16-497) Typical enzymatic assays were performed in a total volume of 10 L in a buffer (200 mM) with pH varying from 4.0 to 11.0. The buffers used were: NaOAc-HOAc, pH 4.0-4.5; MES, pH 5.0-6.0; HEPES, pH 7.0; Tris-HCl, pH 7.5-9.0; and CAPS, pH 10.0-11.0. Reaction system for acceptor LacMU is: CMP-Neu5Ac (1 mM), LacMU (1 mM), and the recombinant Psp2,6ST(15-501)-His 6 (0.3 M). Reaction system for acceptor GalNAc2AA is: CMP-Neu5Ac (4 mM), GalNAc2AA (1 mM), and the recombinant enzyme Psp2,6ST(15-501)-His 6 (6 M) or His 6 -Pd2,6ST(16-497) (30 M). Reaction system for acceptor GalNAcSer is: CMP-Neu5Ac (1 mM), GalNAcSer (1 mM), and the recombinant enzyme Psp2,6ST(15-501)-His 6 or His 6 -Pd2,6ST(16-497) (0.6 M). All reactions were allowed to proceed for 20 min at 20 C. The reaction mixture was quenched by adding ice cold 25% (v/v) acetonitrile to make 100-fold dilution for LacMU, 500-fold dilution for GalNAcSer, or quenched by adding ice cold acetonitrile 30% (v/v) (for GalNAc2AA) to make 80-fold dilution. The samples were then kept on ice until aliquots of 5 L were injected and analyzed by a Shimadzu LC-2010A system equipped with a membrane on-line degasser, a temperature control unit, and a fluorescence detector. A reverse-phase Premier C18 column (250×4.6 mm i.d., 5 m particle size, Shimadzu) protected with a C18 guard column cartridge was used. The mobile phase was 25% (v/v) acetonitrile (for LacMU and GalNAcSer) or 30% (v/v) acetonitrile (for GalNAc2AA). The fluorescent-labeled LacMU and Neu5Ac2-6LacMU were detected by excitation at 325 nm and emission at 372 nm. The fluorescent-labeled GalNAc2AA and Neu5Ac2-6GalNAc2AA were detected by excitation at 315 nm and emission at 400 nm. The fluorescent-labeled GalNAcSer and Neu5Ac2-6GalNAcSer were detected by excitation at 313 nm and emission at 262 nm. All assays were carried out in duplicate. 
Kinetics assay
Enzymatic assays for
General methods
Chemicals were purchased and used without further purification. 1 H NMR (600 MHz) and 13 C NMR (150 MHz) spectra were recorded on a Varian VNMRS 600 MHz spectrometer. High resolution electrospray ionization (ESI) mass spectra were obtained at the Mass Spectrometry Facility in the University of California, Davis. Optical rotation was recorded on an Autopol IV Automatic polarimeter at 589 nm wavelength. Infrared spectra were recorded on a PerkinElmer Spectrum 100 ATR-FTIR. Silica gel 60 Å was used for flash column chromatography. Thin-layer chromatography (TLC) was performed on silica gel plates using p-anisaldehyde sugar stain or 5% sulfuric acid in ethanol stain for detection. Gel filtration chromatography was performed using a column (100 cm × 2.5 cm) packed with BioGel P-2 Fine resins. Sodium pyruvate, ManNAc (1), and mannose (3) and were purchased from Sigma. LacMU, GalNAc derivatives 10-13, ManNAc derivatives 2, 4-9 were synthesized as described previously.
2-5
One-pot three-enzyme preparative-scale synthesis of STn and its derivates -GalNAc glycosides (10-13, 41-55 mg), a sialic acid precursor (1-9, 1.5 equiv.), sodium pyruvate (5.0 equiv.), and CTP (1.5 equiv.) were dissolved in Tris-HCl buffer (10 mL, 100 mM, pH 8.5) containing MgCl 2 (20 mM) and appropriate amounts of Pm aldolase (1.5 mg), NmCSS (1.0 mg), and Psp2,6ST(15-501)-His 6 (2.5-3.0 mg). The pH condition of the mixture was controlled at 8.0 for acceptor 12 or 13 to avoid the loss of Fmoc group, and at 7.5 for donor 5 to avoid the loss of O-acetyl. All other reactions were carried out at pH 8.5. All reactions were incubated in an incubator shaker at room temperature for around 2 days with agitation at 140 rpm. The product formation was monitored by TLC developed with EtOAc:MeOH:H 2 O:HOAc = 4:2:1:0.1 (by volume) and stained with p-anisaldehyde sugar stain. When an optimal yield was achieved, the reaction was stopped by adding the same volume of cold EtOH and kept at 4 C for 30 min. The mixture was then centrifuged and the precipitates were removed. The supernatant was concentrated, passed through a BioGel P-2 gel filtration column, and eluted with water to obtain partially purified product. A silica gel column was then used to obtain the final pure sialylated products using EtOAc:MeOH:H 2 O = 6:2:1 (by volume) as the mobile phase. 2-acetamido-2-deoxy--D-galactopyranoside (14, Neu5Ac2-6GalNAcProN 3 ) . 69 mg, Yield, 76%; white foam. 2-acetamido-2-deoxy--D-galactopyranoside (15, Neu5Gc2-6GalNAcProN 3 '', 1.88 -s, CH 3 ), 1.75 (m, 2H) D-galactopyranoside (16, Kdn2-6GalNAcProN 3 ) . 50 mg, Yield, 60%; white foam. Neu5AcN 3 2-6GalNAcProN 3 ) 
3-Azidopropyl O-(5-acetamido-3,5-dideoxy-D-glycero--D-galacto-2-nonulopyranosylonic acid)-(2→6)-
3-Azidopropyl O-(5-glycolylamido-3,5-dideoxy-D-glycero--D-galacto-2-nonulopyranosylonic acid)-(2→6)-
3-Azidopropyl O-(3-deoxy-D-glycero--D-galacto-2-nonulopyranosylonic acid)-(2→6)-2-acetamido-2-deoxy--
